Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan-based Rescue Therapy for H. Pylori
NCT07130253Not yet recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- Aug 2025
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of vonoprazan in Helicobacter pylori infection (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Eradication rate by intention-to-treat analysis. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07130253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07130253.